APA (7th ed.) Citation

Sachpekidis, C., Anwar, H., Winkler, J. K., Haberkorn, U., Hassel, J. C., & Dimitrakopoulou-Strauss, A. (2018). The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma. European journal of nuclear medicine and molecular imaging, 45(8), . https://doi.org/10.1007/s00259-018-3972-9

Chicago Style (17th ed.) Citation

Sachpekidis, Christos, Hoda Anwar, Julia K. Winkler, Uwe Haberkorn, Jessica C. Hassel, and Antonia Dimitrakopoulou-Strauss. "The Role of Interim 18F-FDG PET/CT in Prediction of Response to Ipilimumab Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine and Molecular Imaging 45, no. 8 (2018). https://doi.org/10.1007/s00259-018-3972-9.

MLA (9th ed.) Citation

Sachpekidis, Christos, et al. "The Role of Interim 18F-FDG PET/CT in Prediction of Response to Ipilimumab Treatment in Metastatic Melanoma." European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 8, 2018, https://doi.org/10.1007/s00259-018-3972-9.